MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells

Experimental and clinical studies have suggested that several neurological disorders are associated with the occurrence of central nervous system neuroinflammation. Metaxalone is an FDA-approved muscle relaxant that has been reported to inhibit monoamine oxidase A (MAO-A). The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallio, Giovanni, D’Ascola, Angela, Cardia, Luigi, Mannino, Federica, Bitto, Alessandra, Minutoli, Letteria, Picciolo, Giacomo, Squadrito, Violetta, Irrera, Natasha, Squadrito, Francesco, Altavilla, Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395141/
https://www.ncbi.nlm.nih.gov/pubmed/34445126
http://dx.doi.org/10.3390/ijms22168425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395141/
https://www.ncbi.nlm.nih.gov/pubmed/34445126
http://dx.doi.org/10.3390/ijms22168425

Ejemplares similares